We are a wholly owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., the world’s largest manufacturer of transdermal patches. We serve as Hisamitsu's platform in US prescription pharmaceuticals, helping Hisamitsu bring the benefits of patch therapy to patients around the world. Hisamitsu develops and markets both prescription and over-the-counter (OTC) pharmaceutical products. Its leading prescription products in Japan are the Mohrus® patch and Mohrus-Tape® ketoprofen pain relief products. Available in nearly 50 countries including the United States, Hisamitsu's leading OTC products are sold under the Salonpas® brand for pain relief, which has been recognized as the world’s number one OTC topical analgesic patch brand for the third consecutive year since 2016 by Euromonitor International Ltd.* Hisamitsu was founded in 1847 and is principally located in Saga, Japan.
Noven and Hisamitsu share a common vision of benefiting patients, and to this end work closely and collaboratively across a range of functions including product development, manufacturing, and business development.
For additional information on Hisamitsu, click here.
For additional information on Hisamitsu's Salonpas® brand of products click here.
*Euromonitor International, a British company headquartered in London, is a leader in international market research with exclusive researchers in over 100 countries.
Research Method: To determine the world’s No. 1 OTC topical analgesic patch brand, London-based Euromonitor International conducts a global market research from March to April every year. In the 10 countries collectively representing more than 70% of the global topical patch product retail market in 2018 (the United States, Brazil, Russia, Italy, Germany, India, Indonesia, Vietnam, China, and Japan), Euromonitor International conducted trade interviews of manufacturers and wholesalers, visited retail outlets for store checks, and compiled the sales figures of patch products by country and brand to calculate the corresponding sales shares.